Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 401 - 450 out of 6,434

Document Document Title
WO/2009/135673
Compounds of the general formula (I) and (II) (including formulae (III) to (V)), wherein X - -CH2-, -O-, -S- n = 0-10 Y = -NH-, -NHSO2-, -NHSO-, -NHCO-, -S-, -O-, -CH=CH- R1-R7, equal or different can be hydrogen, alkyl C1-C4, alkenyl C2...  
WO/2009/135673
Compounds of the general formula (I) and (II) (including formulae (III) to (V)), wherein X - -CH2-, -O-, -S- n = 0-10 Y = -NH-, -NHSO2-, -NHSO-, -NHCO-, -S-, -O-, -CH=CH- R1-R7, equal or different can be hydrogen, alkyl C1-C4, alkenyl C2...  
WO/2009/135673
Compounds of the general formula (I) and (II) (including formulae (III) to (V)), wherein X - -CH2-, -O-, -S- n = 0-10 Y = -NH-, -NHSO2-, -NHSO-, -NHCO-, -S-, -O-, -CH=CH- R1-R7, equal or different can be hydrogen, alkyl C1-C4, alkenyl C2...  
WO/2009/134570
Disclosed are tri-nuclear metal complexes and salts thereof, such as tri-nuclear osmium or ruthenium complexes or salts thereof, suitable for use as electrochemical labels. Also disclosed are oligonucleotide probes with an attached elect...  
WO/2009/134570
Disclosed are tri-nuclear metal complexes and salts thereof, such as tri-nuclear osmium or ruthenium complexes or salts thereof, suitable for use as electrochemical labels. Also disclosed are oligonucleotide probes with an attached elect...  
WO/2009/133269
The invention relates to compounds of the formula (I) in which R1, R2 and R3 are identical or different and each represent a hydrogen atom or a group of the formula (A). The invention can be used for drugs.  
WO/2009/127339
The present invention relates to nanoemulsions comprising alkyl and/or alkenyl ethers of alkyl and/or alkenyl(poly)glycosides, a method for the production thereof and use thereof. The present invention further relates to alkyl and/or alk...  
WO/2009/125819
Disclosed is a compound useful as an active ingredient for a pharmaceutical composition having an α-amylase-inhibiting activity, particularly a pharmaceutical composition for the treatment of diabetes. Studies have been made for discove...  
WO/2009/126556
Compounds, compositions and methods are provided for treatment of diseases or complications associated therewith, in which a selectin plays a role. More specifically, particular glycomimetics and uses thereof are described. For example, ...  
WO/2009/126556
Compounds, compositions and methods are provided for treatment of diseases or complications associated therewith, in which a selectin plays a role. More specifically, particular glycomimetics and uses thereof are described. For example, ...  
WO/2009/126737
The present invention relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, intermediates thereto, and uses thereof. QS-7 is a potent immuno-adjuvant that is significantly less toxic than QS-21, a related saponin ...  
WO/2009/126737
The present invention relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, intermediates thereto, and uses thereof. QS-7 is a potent immuno-adjuvant that is significantly less toxic than QS-21, a related saponin ...  
WO/2009/124468
Anthracycline antibiotic derivatives with anticancer activity, i.e. the compounds of formula (I). The present anthracycline antibiotic derivatives has the same activity as or higher activity than that of the known medicaments such as dox...  
WO/2009/121939
This invention relates to a compound of generic formula (I): (I) as well as a pharmaceutically acceptable salt thereof, a tautomer, optical isomer or a mixture of optical isomers in any proportion, in particular a mixture of enantiomers,...  
WO/2009/121939
This invention relates to a compound of generic formula (I): (I) as well as a pharmaceutically acceptable salt thereof, a tautomer, optical isomer or a mixture of optical isomers in any proportion, in particular a mixture of enantiomers,...  
WO/2009/119692
Disclosed are: a novel glycolipid effective for the treatment of caner or the like; a novel intermediate for the synthesis of the novel glycolipid; a pharmaceutical agent comprising the novel glycolipid; and others. Specifically disclose...  
WO/2009/117196
Methods for utilizing the anticancer properties of terpenoid saponin compounds so as to modulate adhesion proteins, inhibit angiogenesis in tumors, modulate gene expression, modulate angiopoietin, enhance an immune response, provide adju...  
WO/2009/117196
Methods for utilizing the anticancer properties of terpenoid saponin compounds so as to modulate adhesion proteins, inhibit angiogenesis in tumors, modulate gene expression, modulate angiopoietin, enhance an immune response, provide adju...  
WO/2009/112951
Method for preparing the disaccharide [α-D-Gldp(1→3)]-α-L-Rhap-YR wherein Y is selected from -O- and -S- and R is selected from the group consisting of: C1-C6 alkyl, C1-C6 alkenyl, aryl, allyl, -CO-alkyl (C1-C6), -CO-alkenyl (C1-C6),...  
WO/2009/112950
Method for preparing the disaccharide α-D-glucopyranosyl-(1→4)- 2-N-acetyl-2-deoxy-α-D-glucopyranoside, comprising the step of using a mutant of a wild type glycoside hydrolase.  
WO/2009/107853
An agent for preventing or ameliorating skin aging, which exhibits a more excellent effect on the suppression of formation, or the amelioration, of wrinkles on the skin or sagging skin. An agent for preventing or ameliorating skin aging,...  
WO/2009/107853
An agent for preventing or ameliorating skin aging, which exhibits a more excellent effect on the suppression of formation, or the amelioration, of wrinkles on the skin or sagging skin. An agent for preventing or ameliorating skin aging,...  
WO/2009/108680
Exemplary embodiments of this invention encompass a method for degrading rebaudioside A and the rebaudioside A derivative products derived therefrom. In particular, this invention relates to a method for degrading rebaudioside A composit...  
WO/2009/108680
Exemplary embodiments of this invention encompass a method for degrading rebaudioside A and the rebaudioside A derivative products derived therefrom. In particular, this invention relates to a method for degrading rebaudioside A composit...  
WO/2009/101213
The present invention relates to an enzyme called chitinosanase which is obtained from the fungus Alternaria alternate, said enzyme breaking down chitosane and specifically cleaving the glycosidic GIcNAc-GIcN bond in chitosane, DNA seque...  
WO/2009/102928
The invention provides compounds and methods for making adenosine-ribofuranoside tetraphosphate compounds. The compounds are contemplated to have activity at the P2Y receptor and may be used in the treatment of medical disorders such as ...  
WO/2009/102736
The invention disclosed in this document is related to the field of pesticides and their use in controlling pests. A compound having the following structure is disclosed.  
WO/2009/098400
The invention relates to a chemical compound of the disaccharide type of the following general formula (A): where, Z = O or S; X1 = azido or NHCOR3 where R3 = 1 -5 c alkyl or aryl, X2 = benzyl, H or sulfonate, X3 = -CH2φ, -CHφ forming ...  
WO/2009/095588
The invention relates to compounds of the formula (I) in which: R1 = OH or NH2; OR2, OR3, OR4 and OR5 form alcohol, ether, ester, carbonate, carbamate, sulphonate or sulphamate functions; and if R5 = H, if R2 =R3=R4, then R2, R3 and R4 ...  
WO/2009/095588
The invention relates to compounds of the formula (I) in which: R1 = OH or NH2; OR2, OR3, OR4 and OR5 form alcohol, ether, ester, carbonate, carbamate, sulphonate or sulphamate functions; and if R5 = H, if R2 =R3=R4, then R2, R3 and R4 ...  
WO/2009/097596
The present disclosure provides compositions and methods for the treatment and elimination of chronic intracellular infections in cells or organisms. The compositions may include one or more acidic substances and one or more antimicrobia...  
WO/2009/096503
Disclosed is a compound having a novel structure, few adverse side effects and an excellent inhibitory activity on human SGLT1 and/or SGLT2, or a hydrate of the compound. Also disclosed is a pharmaceutical composition for treating and/or...  
WO/2009/093604
This object aims to provide an organic nanotube manufacturing method and an organic nanotube manufacturing device that pressurize an organic nanotube material dispersion solution comprised of an organic nanotube material and an organic s...  
WO/2009/086720
2,3,4,6-tetra-O-acetyl-D-glucopyranosyl-[N,N'-di-(2-chloroet hyl)]-phosphoric acid diamide I, its α-configuration II and its β-configuration III. These compounds show inhibitory action on transplantation tumors in mouse from the pharma...  
WO/2009/087677
The present invention relates to an improved process for the preparation of 2, 3, 6, 3', 4'- Penta-O-acetylsucrose 6-PAS), formula (V) and sucralose, formula (I).  
WO/2009/088618
A method for the aralkylation of anthracyclins by utilizing an aralkylating agent R3-CH2X (for example, BnBr) in accordance with the reaction pathway describe by the scheme shown in Fig. 1. The present invention recognizes that 4-R1, 3'-...  
WO/2009/080215
Suggested are alkylene oxide adducts of oligosaccharides, obtainable in that an aqueous solution of at least one water-soluble oligosaccharide is subjected to alkoxylation within a temperature range of 90 to 160 °C.  
WO/2009/081211
A process of obtaining a saponin-rich component from a plant of the Araliaceae family, the process comprising the steps of: (a) treating a portion of the plant with an extraction solvent in which saponin-containing compounds are soluble;...  
WO/2009/081211
A process of obtaining a saponin-rich component from a plant of the Araliaceae family, the process comprising the steps of: (a) treating a portion of the plant with an extraction solvent in which saponin-containing compounds are soluble;...  
WO/2009/078462
Disclosed is a sugar chain primer represented by the following general formula (I). Lac-O-Ck:m(n) (I) (In the formula (I), Ck represents an alkenyl chain; m represents the total number of double bonds; and n represents the positions of t...  
WO/2009/075186
Disclosed is a method for producing a 4-deoxy-4-fluoro-D-glucose derivative, wherein a D-galactose derivative is reacted with sulfuryl fluoride (SO2F2), trifluoromethanesulfonyl fluoride (CF3SO2F) or perfluorobutanesulfonyl fluoride (C4F...  
WO/2009/068531
The present invention relates to a compound The instant invention relates to a compound of formulae (I A), (I B), (X A), (X B), (Y A) or (Y B), wherein R' represents (formula) and R' represents hydrogen, hydroxy, C1-C7alkoxy, C1-C8-alkan...  
WO/2009/069668
Disclosed is a means which is effective for the treatment of melanoma. Specifically disclosed is an agent for increasing the expression of a malignant melanoma antigen, which comprises a compound selected from the group consisting of met...  
WO/2009/067846
The invention discloses a purifying method of monoglycoside acid which comprises selective oxidizing primary hydroxy group of the monoglycoside, exchanging the reacted composite liquid through an activated strong acid cation exchange res...  
WO/2009/069800
Disclosed are a novel aminoglycoside antibiotic, a production method thereof, and a pharmaceutical use thereof. Specifically disclosed are a compound represented by the formula (I) below, a production method thereof, and a use thereof as...  
WO/2009/066117
The invention relates to the use of ethylenediamine tetraacetic acid (EDTA) and its derivatives, i.e. its salts and complexes for prevention and treatment of bacterial intestinal diseases of pigs and for increasing the effects of antibio...  
WO/2009/067692
Compounds of structure (I): having antibacterial activity are disclosed, including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, Q3, R8 and R9 are as defined herein. Methods associated with prepar...  
WO/2009/059945
1,2-Dideoxy-1,2-diamino oligosaccharides and polysaccharides as shown in General Formula (1) and derivatives thereof are described, and methods suitable for their preparation in free-base, salt or metal-complexed form. In addition, new u...  
WO/2009/059945
1,2-Dideoxy-1,2-diamino oligosaccharides and polysaccharides as shown in General Formula (1) and derivatives thereof are described, and methods suitable for their preparation in free-base, salt or metal-complexed form. In addition, new u...  
WO/2009/060086
The present invention relates to compounds consisting of glycolipids covalently bound to an antigen or a drug via a linker. The said compounds are able to induce a stronger immune response than a composition comprising separated glycolip...  

Matches 401 - 450 out of 6,434